Timothy Hatlen to Recombinant Fusion Proteins
This is a "connection" page, showing publications Timothy Hatlen has written about Recombinant Fusion Proteins.
Connection Strength
0.047
-
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. Ann Intern Med. 2022 09; 175(9):1266-1274.
Score: 0.047
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.